Skip to main content
. 2011 Jun 29;12:30. doi: 10.1186/1471-2369-12-30

Figure 2.

Figure 2

Kaplan-Meier analysis for the cumulative percentage of surviving patients at 90 days according to different CRP/prealbumin levels. The median of CRP/prealbumin was used as the cut-off point to divide the patients with AKI into 2 groups. Patients with higher levels of CRP/prealbumin (n = 78) had a significantly lower survival rate in these patients (log rank test, p < 0.01).